Zobrazeno 1 - 10
of 11
pro vyhledávání: '"William, Slayton"'
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 3, Pp 964-972 (2017)
The association between nephrotic syndrome (NS), hemophagocytic lymphohistiocytosis (HLH), and certain paraneoplastic syndromes has been documented in the literature. However, nephrotic changes as part of paraneoplastic syndromes are rare in lymphoid
Externí odkaz:
https://doaj.org/article/def3245be0a34b998a9926c0cf137989
Autor:
Nick Figura, MD, Stella Flampouri, PhD, Nancy P. Mendenhall, MD, Christopher G. Morris, MS, Barry McCook, MD, Savas Ozdemir, MD, William Slayton, MD, Eric Sandler, MD, Bradford S. Hoppe, MD, MPH
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 2, Pp 197-203 (2017)
Purpose: This study analyzed the impact of pretreatment positron emission tomography/computed tomography (PET/CT) scans on involved site radiation therapy (ISRT) field design and pattern of relapse among patients with Hodgkin lymphoma (HL). Methods a
Externí odkaz:
https://doaj.org/article/167ea8cfc20d4e90a385867bf016ec34
Autor:
Andrew L. Walker, Emily Marchi, Ana Puig, William Slayton, Virginia Dodd, Megan A. McVay, Melvin D. Livingston
Publikováno v:
Journal of Palliative Medicine. 25:1186-1196
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42c1207f0179a4ed7c7f3146a45c6c38
https://doi.org/10.1089/jpm.2021.0426
https://doi.org/10.1089/jpm.2021.0426
Autor:
Ally Fraser, Paul Castillo, Erika Cascio, Giselle Moore‐Higgs, Nosha Farhadfar, John Fort, William Slayton, Jatinder Lamba, Biljana Horn
Publikováno v:
Pediatric Blood & Cancer. 70
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95f6d13261038d0bf0043ef47ac694c1
https://doi.org/10.1002/pbc.30322
https://doi.org/10.1002/pbc.30322
Autor:
Monrat, Chulanetra, Atthapan, Morchang, Elias, Sayour, Lamis, Eldjerou, Rowan, Milner, Joanne, Lagmay, Matt, Cascio, Brian, Stover, William, Slayton, Wanpen, Chaicumpa, Pa-Thai, Yenchitsomanus, Lung-Ji, Chang
Publikováno v:
American journal of cancer research. 10(2)
Since the prognosis for children with high-risk osteosarcoma (OS) remains suboptimal despite intensive multi-modality therapies, there is a clear and urgent need for the development of targeted therapeutics against these refractory malignancies. Chim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7368cd788c045cda06863ba381bf6afb
https://pubmed.ncbi.nlm.nih.gov/32195035
https://pubmed.ncbi.nlm.nih.gov/32195035
Autor:
Emma H, Rosenau, Michele W, Sugrue, Michael, Haller, Diann, Fisk, Susan S, Kelly, Myron, Chang, Wei, Hou, Lamis, Eldjerou, William, Slayton, Christopher R, Cogle, John R, Wingard
Publikováno v:
Transfusion. 52(10)
Autologous umbilical cord blood (AutoUCB) has historically been cryopreserved for potential use in hematopoietic transplantation. Increasingly, private AutoUCB banking is performed for therapies unavailable today. A Phase I trial using AutoUCB treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::822e30aedb7373fdb41556589d09f0e5
https://pubmed.ncbi.nlm.nih.gov/22321210
https://pubmed.ncbi.nlm.nih.gov/22321210
Autor:
Sheilagh Barclay, Laura C. Bowman, Michael C. Briones, David C. Burghardt, Mitchell S. Cairo, Kenneth A. Clark, Jorge A. Di Paola, Anne F. Eder, David F. Friedman, Jed B. Gorlin, Alfred J. Grindon, Ann E. Haight, Lauren Harrison, Christopher D. Hillyer, Krista L. Hillyer, Heather A. Hume, Faranak Jamali, Cassandra D. Josephson, Susan T. Johnson, Grace S. Kao, Haewon C. Kim, Karen E. King, Lennart E. Lögdberg, Bruce C. McLeod, Lisa M. Montenegro, Paul M. Ness, Anne-Monique Nuyt, Alexandros Panagopoulos, Patricia T. Pisciotto, Tina M. Pugh, Thomas J. Raife, Jayashree Ramasethu, John D. Roback, Nancy Robitaille, S. Gerald Sandler, Matthew Saxonhouse, William Slayton, Steven Sloan, Martha C. Sola, Ronald G. Strauss, Maria Luisa Sulis, Brian M. Wicklund, Edward C.C. Wong
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69869751e7ef8c7c9df546937a76c601
https://doi.org/10.1016/b978-012348776-6/50003-0
https://doi.org/10.1016/b978-012348776-6/50003-0
Autor:
Meenakshi Devidas, Alexander Aledo, W. Paul Bowman, Robert Rutledge, William L. Carroll, Andrew J. Carroll, Michael E. Trigg, William Slayton, Nyla A. Heerema, Bruce M. Camitta, Harland Sather, Laura Burden, Bernice Pasut, Naomi Winick, Kirk R. Schultz, Paul S. Gaynon, Stephen P. Hunger, Dean Jorstad, Tammie Eslinger, S.M. Davies, Michael J. Borowitz, Chenguang Wang
Publikováno v:
Blood. 110:4-4
Ph+ ALL remains one of the highest risk subsets of childhood ALL. The COG AALL0031 protocol (open 2002 – 2006) gave imatinib at 340 mg/m2 for an increasing number of days in combination with an intensive chemotherapy backbone. Cohorts received 42 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::419990e1d7e6db96118a0f31e2b395ae
https://doi.org/10.1182/blood.v110.11.4.4
https://doi.org/10.1182/blood.v110.11.4.4
Autor:
Nyla A. Heerema, W. Paul Bowman, Julie M. Gastier-Foster, Kirk R. Schultz, William Slayton, Stephen P. Hunger, William L. Carroll, Alexander Aledo, C. L. Willman, Andrew J. Carroll, Naomi Winick, Harland Sather, Michael J. Borowitz
Publikováno v:
Blood. 108:283-283
We tested whether imatinib mesylate, the first Bcr/Abl tyrosine kinase inhibitor, can be given safely in combination with chemotherapy for children with Ph+ ALL in an effort to improve outcome. Imatinib alone has a number of known side effects, inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14305d4a5841176ee35b479e4b47dddb
https://doi.org/10.1182/blood.v108.11.283.283
https://doi.org/10.1182/blood.v108.11.283.283
Publikováno v:
Southern Medical Journal. 88:S99
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8f132208680ecd57b88551e36380359
https://doi.org/10.1097/00007611-199510001-00226
https://doi.org/10.1097/00007611-199510001-00226